<h4>Backround</h4>Human-induced pluripotent stem cells (hiPSCs) have emerged as a promising source of transplantable insulinproducing cells (IPCs) to restore insulin levels in Type 1 Diabetes (T1D) patients. The gene discussed is INS; the disease is type 1 diabetes mellitus.